Corneal Diseases
23
5
5
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.0%
3 terminated out of 23 trials
78.6%
-7.9% vs benchmark
13%
3 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (23)
Data Gathering for A10900
Efficacy of Nanodropper-mediated Topical Anesthetic
4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect
Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema
Evaluation of the Safety of Terahertz Scanning System on Corneas
Corneal Findings in Patients Treated With Belantamab Mafodotin
The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
A Randomized Study of Smile Exercise for Dry Eye
Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3
Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas
Keratoconus, Corneal Diseases and Transplant Registry
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches
Functional Antigen Matching in Corneal Transplantation
Autologous Serum Eye Drops With Contact Lenses for Corneal Epithelial Defects
Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions
Study of Dehydrex in Patients With Corneal Erosion
Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy